Concepedia

Kim Frederix

KF

7

Publications

266

Citations

7

H-Index

2007

Active since

Affiliations

Maastricht University(Current)

Maastricht University Medical Centre

National Institute for Public Health and the Environment

University of Liège

Kim Frederix is an author at Maastricht University specializing in medicine, immunology, and tumor biology.

Top concepts

Publications per year

2007–2019

7

Publications

7

P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation

Christelle Lecut, Kim Frederix, Daniel M. Johnson et al. · The Journal of Immunology · 2009 · 105 citations · Full text

Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors

Florence Schramme, Stefano Crosignani, Kim Frederix et al. · Cancer Immunology Research · 2019 · 67 citations · Full text

Overexpression of CD39 in Mouse Airways Promotes Bacteria-Induced Inflammation

Emilie Théâtre, Kim Frederix, William Guilmain et al. · The Journal of Immunology · 2012 · 25 citations · Full text

, , +13

Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors

Joseph R. Tumang, Bruno Gomes, Martin Wythes et al. · Cancer Research · 2016 · 25 citations

, , +20

A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance

Kim Frederix, Ingeborg M. Kooter, René van Oerle et al. · Thrombosis Journal · 2008 · 17 citations · Full text

Rows per page

1–5 of 7